News / Africa

Tough TB Responds to Drug Treatment

A young patient with potentially fatal MDR TB in isolation in a hospital in South Africa (Photo: D.Taylor)
A young patient with potentially fatal MDR TB in isolation in a hospital in South Africa (Photo: D.Taylor)

Multimedia

Audio
Joe DeCapua
An antibiotic used to treat severe infections shows promise against a very resistant and deadly form of tuberculosis. XDR-TB is resistant to at least four of the drugs used most often against the disease.


Extensively drug resistant tuberculosis – or XDR-TB – is still considered rare, although cases have been reported in nearly 80 countries. Health officials believe the number of XDR-TB cases is underreported because there’s no specific test for it.

It can be cured, but the odds against that happening are often quite high. It can kill quickly, especially if a person is co-infected with HIV, the virus that causes AIDS.

Dr. Ray Chen, a staff clinician at the National Institute of Allergy and Infectious Diseases, says XDR-TB is the next step after MDR-TB, or multi-drug resistant tuberculosis, which is a lot more common.

“That’s been a known problem for many years, primarily as a result of people who don’t take their drugs well. And then the tuberculosis bug slowly develops resistance to the drugs that are used,” he said.

MDR-TB is resistant to two of the top line drugs used for standard tuberculosis therapy. When the disease becomes resistant to two additional first-line drugs, it’s upgraded to XDR-TB.

“It came to world attention in 2006 in a study in South Africa where a number of patients were found to have this extensive resistance to tuberculosis drugs, and they had a very high mortality rate. And so it became recognized as a major problem for tuberculosis,” he said.

In fact, the mortality rate was as high at 90 percent in patients also infected with HIV.

Standard TB treatment can take up to six months. MDR-TB treatment can last between 18 and 24 months.

So researchers knew that more drugs were needed to tackle the various forms of TB.  They had heard of some informal studies using the drug linezolid on TB patients with some success. But there was no formal study.

Linezolid is a drug that’s already on the market and it’s approved for the use of resistant bacteria, which we call gram-positive bacteria that don’t respond to typical antibiotics.

To find out, researchers tested linezolid on 41 patients with XDR-TB. The patients already had been treated for six months with the best TB drugs available, but failed to respond. Chen said linezolid was added to their regimen.

“We found that adding the linezolid had a significant effect and that most of the patients converted their sputum from showing tuberculosis to not having tuberculosis in the sputum by six months. About 87 percent of the patients became negative for tuberculosis within six months. So it showed a very good response,” he said.

That’s the good news. The bad news is many of the patients suffered severe side effects. These include nerve problems with hands and feet going numb. There were also eye problems and abnormalities with red and white blood cells. Use of the drug was stopped before any of the patients suffered permanent damage.

As a result, Chen said more studies are needed to determine whether it can safely be used on a large-scale in combination with other drugs. He also says new, potent antibiotics will be coming on the market and these may be tested on TB, as well.

You May Like

US Investors Eye IPO for China's Alibaba

E-commerce giant handled 80 percent of China's online business last year, logging more Internet transactions than US-based Amazon.com and eBay combined More

Video Uneasy Calm Settles Over Israel, Gaza Strip

As cease-fire begins, Palestinians celebrate in streets; Israelis remain wary More

Video Chinese Doctors Use 3-D Spinal Implant

In treatment of a 12-year-old boy Chinese doctors used a 3-D printer and special software to create an exact replica of vertebra More

Featured Videos

Your JavaScript is turned off or you have an old version of Adobe's Flash Player. Get the latest Flash player.
Chinese Doctors Use 3-D Spinal Implanti
X
August 27, 2014 4:53 PM
A Chinese boy suffering from a debilitating bone disease has become the first patient with a part of his spine created in a three-dimensional printer. Doctors say he will soon regain normal mobility. VOA’s George Putic reports.
Video

Video Chinese Doctors Use 3-D Spinal Implant

A Chinese boy suffering from a debilitating bone disease has become the first patient with a part of his spine created in a three-dimensional printer. Doctors say he will soon regain normal mobility. VOA’s George Putic reports.
Video

Video Uneasy Calm Settles Over Israel, Gaza Strip

Israel and the Gaza Strip have been calm since a cease-fire set in Tuesday evening, ending seven weeks of hostilities. Hamas, which controls Gaza, declared victory. Israelis were more wart. VOA’s Scott Bobb reports from Jerusalem.
Video

Video India’s Leprosy Battle Stymied by Continuing Stigma

Medical advancements in the treatment of leprosy have greatly diminished its impact around the world, largely eliminating the disease from most countries. India made great strides in combating leprosy, but still accounts for a majority of the world’s new cases each year, and the number of newly infected Indians is rising - more than 130,000 recorded last year. Doctors there say the problem has more to do with society than science. VOA News reports from Kolkata.
Video

Video Northern California Quake: No Way to Know When Next One Will Hit

A magnitude 6.0 earthquake rocked northern California’s Napa Valley on Sunday. Roads twisted and water mains burst. It was the wine country’s most severe quake in 15 years, and while hospitals treated many people, no one was killed. Arash Arabasadi has more from Washington on what the future may hold for those residents living on a fault line.
Video

Video Scientists Unlock Mystery of Bird Flocks

How can flocks of birds, schools of fish or herds of antelope suddenly change direction -- all the individuals adjusting their movement in concert, at seemingly the same time? British researchers now have some insights into this behavior, which has puzzled scientists for a long time. VOA's George Putic has more.
Video

Video Ukraine: Captured Troops Proof of Russian Role in Separatist Fight

Ukrainian officials say they have captured Russian soldiers on Ukrainian territory -- the latest accusation of Moscow's involvement in the conflict in eastern Ukraine. VOA's Gabe Joselow reports from the Ukrainian side of the battle, where soldiers are convinced of Russia's role.
Video

Video Rubber May Soon Come From Dandelions

Synthetic rubber has been around for more than a century, but quality tires for cars, trucks and aircraft still need up to 40 percent or more natural rubber content. As the source of natural rubber, the rubber tree, is prone to disease and can be affected by bad weather. So scientists are looking for replacements. And as VOA’s George Putic reports, they may have found one in a ubiquitous weed.
Video

Video Jewish Life in Argentina Reflected in Yiddish Tango

Jewish people from across Europe and Russia have been immigrating to Argentina for hundreds of years. They brought with them dance music that were eventually mixed with Argentine tango. The result is Yiddish tango -- a fusion of melodies and cultural experiences that is still evolving today. Elizabeth Lee reports from the Skirball Cultural Center in Los Angeles, where one band is bringing Yiddish tango to an American audience.

AppleAndroid